Trends in cardiovascular risk factors · Trends in cardiovascular risk factors Panos Stafylas, MD,...

32
Trends in cardiovascular risk factors Panos Stafylas, MD, MSc, PhD Cardiologist/ΗΤΑ Consultant Scientific Director, HealThink Thessaloniki, Greece

Transcript of Trends in cardiovascular risk factors · Trends in cardiovascular risk factors Panos Stafylas, MD,...

Page 1: Trends in cardiovascular risk factors · Trends in cardiovascular risk factors Panos Stafylas, MD, MSc, PhD Cardiologist/ΗΤΑ Consultant Scientific Director, HealThink Thessaloniki,

Trends in cardiovascular risk factors

Panos Stafylas, MD, MSc, PhD

Cardiologist/ΗΤΑ ConsultantScientific Director, HealThink

Thessaloniki, Greece

Page 2: Trends in cardiovascular risk factors · Trends in cardiovascular risk factors Panos Stafylas, MD, MSc, PhD Cardiologist/ΗΤΑ Consultant Scientific Director, HealThink Thessaloniki,

Declaration of interest

• I have nothing to declare

Page 3: Trends in cardiovascular risk factors · Trends in cardiovascular risk factors Panos Stafylas, MD, MSc, PhD Cardiologist/ΗΤΑ Consultant Scientific Director, HealThink Thessaloniki,

Eurostat Database (data refer to Cyprus, 2014).

CVDs remain the main cause of mortality

5.500 θάνατοι

Page 4: Trends in cardiovascular risk factors · Trends in cardiovascular risk factors Panos Stafylas, MD, MSc, PhD Cardiologist/ΗΤΑ Consultant Scientific Director, HealThink Thessaloniki,

GBD 2017, Causes of Death Collaborators. Lancet 2018

CVD main cause of death for

male 35+ and female 55+

Page 5: Trends in cardiovascular risk factors · Trends in cardiovascular risk factors Panos Stafylas, MD, MSc, PhD Cardiologist/ΗΤΑ Consultant Scientific Director, HealThink Thessaloniki,

European Heart Journal, Volume 37, Issue 42, 7 November 2016, Pages 3232–3245, https://doi.org/10.1093/eurheartj/ehw334

The content of this slide may be subject to copyright: please see the slide notes for details.

Figure 3 Estimated DALYs per 1000 population for all

cardiovascular diseases, coronary heart disease and stroke, WHO

...

Cyprus: 31.820 DALYs

~ 37 DALYs/1000 individuals

(23%)

Page 6: Trends in cardiovascular risk factors · Trends in cardiovascular risk factors Panos Stafylas, MD, MSc, PhD Cardiologist/ΗΤΑ Consultant Scientific Director, HealThink Thessaloniki,

GBD: Leading CVD Risk Factors

GBD 2017, Risk Factor Collaborators, Lancet 2018

Page 7: Trends in cardiovascular risk factors · Trends in cardiovascular risk factors Panos Stafylas, MD, MSc, PhD Cardiologist/ΗΤΑ Consultant Scientific Director, HealThink Thessaloniki,

GBD 2017, Risk Factor Collaborators, Lancet 2018

Τεκμηριωμένοι παράγοντες κινδύνου για ΣΝ

1. Ηλικία

2. Φύλο

3. Οικογενειακό ιστορικό

4. Γονότυπος

1. Αρτηριακή υπέρταση

2. Υπερλιπιδαιμία

3. Σακχαρώδης διαβήτης

4. Κάπνισμα

5. Παχυσαρκία

6. Διατροφή

7. Καθιστική ζωή

8. Ψυχοκοινωνικοί παράγοντες

Page 8: Trends in cardiovascular risk factors · Trends in cardiovascular risk factors Panos Stafylas, MD, MSc, PhD Cardiologist/ΗΤΑ Consultant Scientific Director, HealThink Thessaloniki,

Mean systolic blood pressure (mmHg), 1980-2014

ESC CVD Statistics 2017

Prevalence EU 18.3% / 27.3%(F / M, high income EU countries 2014)

Prevalence CY 15.8% / 23.5%

Page 9: Trends in cardiovascular risk factors · Trends in cardiovascular risk factors Panos Stafylas, MD, MSc, PhD Cardiologist/ΗΤΑ Consultant Scientific Director, HealThink Thessaloniki,

Η μείωση της ΑΠ κατά 2 mmΗg μειώνει τον κίνδυνο κατά 7–10%

• Μετα-ανάλυση 61 προοπτικών μελετών παρατήρησης

• 1 εκατομμύριο ενήλικες

• 12.7 εκατομμύρια ανθρωπο-έτη

2 mmHg

μείωση της μέσης ΣΑΠ

- 10% θνητότητα από ΑΕΕ

- 7% θνητότητα από Ισχ. Καρδιοπάθεια

Lewington et al. Lancet 2002;360:1903–13

Page 10: Trends in cardiovascular risk factors · Trends in cardiovascular risk factors Panos Stafylas, MD, MSc, PhD Cardiologist/ΗΤΑ Consultant Scientific Director, HealThink Thessaloniki,

Υπερλιπιδαιμία

Lewington et al. Lancet 2007 NCEP report. Circulation 2004

Page 11: Trends in cardiovascular risk factors · Trends in cardiovascular risk factors Panos Stafylas, MD, MSc, PhD Cardiologist/ΗΤΑ Consultant Scientific Director, HealThink Thessaloniki,
Page 12: Trends in cardiovascular risk factors · Trends in cardiovascular risk factors Panos Stafylas, MD, MSc, PhD Cardiologist/ΗΤΑ Consultant Scientific Director, HealThink Thessaloniki,

Cholesterol(≥5.0 mmol/L / ≥ 6.2 mmol/L, M/F)

Prevalence CY:

• 57.1% (>5 mmol/L)

• 17.7% (>6.2 mmol/L)

Vs ESC 52.9% / 16.3%

Page 13: Trends in cardiovascular risk factors · Trends in cardiovascular risk factors Panos Stafylas, MD, MSc, PhD Cardiologist/ΗΤΑ Consultant Scientific Director, HealThink Thessaloniki,

DM not only substantially increases the risk of CVD

but also magnifies the effect of other RF for CVD

MRFIT=Multiple Risk Factor Intervention Trial

*Risk factors analyzed: smoking, hypercholesterolemia, and hypertension.

Number of risk factors*

MRFIT. Diabetes Care 1993

0

20

40

60

80

100

120

140

None One only Two only All three

612

22

47

31

59

91

125ΜΗ διαβητικοί (n=342,815)

ΔΙΑΒΗΤΙΚΟΙ (n=5,163)

Page 14: Trends in cardiovascular risk factors · Trends in cardiovascular risk factors Panos Stafylas, MD, MSc, PhD Cardiologist/ΗΤΑ Consultant Scientific Director, HealThink Thessaloniki,

Diabetes (EU prevalence 6.5% vs Cyprus 9.3%)

IDF Diabetes Atlas 2018

• 451 million (2017) → 693 million(2045)

• Half of diabetics are undiagnosed

• +374 million people with impaired glucose tolerance (IGT)

• Approximately 5 million deaths worldwide were attributable to

diabetes (2017)

• Global healthcare expenditure USD 850 billion (2017)

ESC CVD Statistics 2017

Page 15: Trends in cardiovascular risk factors · Trends in cardiovascular risk factors Panos Stafylas, MD, MSc, PhD Cardiologist/ΗΤΑ Consultant Scientific Director, HealThink Thessaloniki,

Obesity: Age-standardized mean BMI (kg/m2), 18+ years, 1980–2014, ESC member countries

ESC CVD Statistics 2017

Page 16: Trends in cardiovascular risk factors · Trends in cardiovascular risk factors Panos Stafylas, MD, MSc, PhD Cardiologist/ΗΤΑ Consultant Scientific Director, HealThink Thessaloniki,

Overweight / Obesity

• Increasing BMI

& prevalence

• > 1/5 adults

(CY: >1/4)

• > 1/8 girls

• > 1/6 boys

ESC CVD Statistics 2017

Page 17: Trends in cardiovascular risk factors · Trends in cardiovascular risk factors Panos Stafylas, MD, MSc, PhD Cardiologist/ΗΤΑ Consultant Scientific Director, HealThink Thessaloniki,

2 στους 5 θανάτους στην Κυπρο

μπορουν να αποδοθουν σε

συμπεριφορικους παράγοντες κινδυνου

State of Health in the EU: Cyprus. OECD 2019

Page 18: Trends in cardiovascular risk factors · Trends in cardiovascular risk factors Panos Stafylas, MD, MSc, PhD Cardiologist/ΗΤΑ Consultant Scientific Director, HealThink Thessaloniki,

Smoking

• Reduced prevalence,

mainly in men

ESC CVD Statistics 2017

Page 19: Trends in cardiovascular risk factors · Trends in cardiovascular risk factors Panos Stafylas, MD, MSc, PhD Cardiologist/ΗΤΑ Consultant Scientific Director, HealThink Thessaloniki,

Smoking

• EU 28%

• CY 39.2% /

14.3% (2008)

ESC CVD Statistics 2017

Page 20: Trends in cardiovascular risk factors · Trends in cardiovascular risk factors Panos Stafylas, MD, MSc, PhD Cardiologist/ΗΤΑ Consultant Scientific Director, HealThink Thessaloniki,

ESC CVD Statistics 2017

Total energy consumption Fat consumption

Vegetable consumption Fruit consumption

Diet

Page 21: Trends in cardiovascular risk factors · Trends in cardiovascular risk factors Panos Stafylas, MD, MSc, PhD Cardiologist/ΗΤΑ Consultant Scientific Director, HealThink Thessaloniki,

Δίαιτα

Dauchet et al. J Nutr 2007

Sofi et al. BMJ 2008

Μείωση των στεφανιαίων

επεισοδίων κατά 7% ανά μερίδα

φρούτου/λαχανικού ανά ημέρα

Η μεσογειακή δίαιτα μειώνει κατά

9% τον CV κίνδυνο

Page 22: Trends in cardiovascular risk factors · Trends in cardiovascular risk factors Panos Stafylas, MD, MSc, PhD Cardiologist/ΗΤΑ Consultant Scientific Director, HealThink Thessaloniki,

Physical Activity

Walking MET-h/w)

Boone Heinonen et al. Obes Rev 2009

30 – 40% μείωση

του κινδύνου για ΣΝ

Page 23: Trends in cardiovascular risk factors · Trends in cardiovascular risk factors Panos Stafylas, MD, MSc, PhD Cardiologist/ΗΤΑ Consultant Scientific Director, HealThink Thessaloniki,

Άσκηση

Παράγοντας

κινδύνουΑπώλεια βάρους Φυσική δραστηριότητα

Υπέρταση ↓↓↓ ↓↓↓

Διαβήτης τ2 ↓↓↓ ↓↓

Χοληστερόλη Σαφής βελτίωση Σαφής βελτίωση

Στεφανιαία νόσος ↓↓ ↓↓↓

Εγκεφαλικό ↓ ↓↓

Άπνοιες στον ύπνο ↓↓ Άγνωστο

Νοητική λειτουργία Πιθανή βελτίωση Πιθανή βελτίωση

Manson et al. Arch Intern Med 2004

Page 24: Trends in cardiovascular risk factors · Trends in cardiovascular risk factors Panos Stafylas, MD, MSc, PhD Cardiologist/ΗΤΑ Consultant Scientific Director, HealThink Thessaloniki,

ESC CVD Statistics 2017

Physical Activity

Prevalence of insufficiently

active adults

ESC: 22.7% / 30.1% (M/F)

CY: 29.3% / 41.5% (M/F)

Definition: % of defined population

attaining less than 150 min of

moderate-intensity physical activity

per week or less than 75 min of

vigorous-intensity physical activity

per week (based on self-reported

physical activity captured using the

GPAQ).

Page 25: Trends in cardiovascular risk factors · Trends in cardiovascular risk factors Panos Stafylas, MD, MSc, PhD Cardiologist/ΗΤΑ Consultant Scientific Director, HealThink Thessaloniki,
Page 26: Trends in cardiovascular risk factors · Trends in cardiovascular risk factors Panos Stafylas, MD, MSc, PhD Cardiologist/ΗΤΑ Consultant Scientific Director, HealThink Thessaloniki,

Ψυχοκοινωνικοί παράγοντες.Στρες, κατάθλιψη και κίνδυνος ΟΕΜ

INTERHEART. Lancet 2005

Page 27: Trends in cardiovascular risk factors · Trends in cardiovascular risk factors Panos Stafylas, MD, MSc, PhD Cardiologist/ΗΤΑ Consultant Scientific Director, HealThink Thessaloniki,
Page 28: Trends in cardiovascular risk factors · Trends in cardiovascular risk factors Panos Stafylas, MD, MSc, PhD Cardiologist/ΗΤΑ Consultant Scientific Director, HealThink Thessaloniki,

Age-standardised prevalence of CVD per 100 000

in Cyprus (1990 – 2015)

0

1000

2000

3000

4000

5000

6000

7000

1990 2000 2010 2015

Male Female

ESC CVD Statistics 2017

Page 29: Trends in cardiovascular risk factors · Trends in cardiovascular risk factors Panos Stafylas, MD, MSc, PhD Cardiologist/ΗΤΑ Consultant Scientific Director, HealThink Thessaloniki,

Incidence of CVD in Cyprus (1990 – 2015)

0

500

1000

1500

2000

2500

3000

3500

1990 2000 2010 2015

Male Female

ESC CVD Statistics 2017

Page 30: Trends in cardiovascular risk factors · Trends in cardiovascular risk factors Panos Stafylas, MD, MSc, PhD Cardiologist/ΗΤΑ Consultant Scientific Director, HealThink Thessaloniki,

CVD Mortality Forecast to 2040

Foreman et al. Lancet 2018

Page 31: Trends in cardiovascular risk factors · Trends in cardiovascular risk factors Panos Stafylas, MD, MSc, PhD Cardiologist/ΗΤΑ Consultant Scientific Director, HealThink Thessaloniki,

Key messages

HealThink©2019

• CVD remain the main cause of death despite of the progress

• Known RF account for more than 90% of observed CVD

• The most important way to prevent CVD is to promote a healthy lifestyle throughout life

• Assess and manage all RF

• Key interventions:➢Education campaingns focusing on lifestyle and behavior change

early in life

➢Assess and manage effectively all RF

➢Emergency services and technical capacity for acute and chronicCVD

➢Universal health coverage

Page 32: Trends in cardiovascular risk factors · Trends in cardiovascular risk factors Panos Stafylas, MD, MSc, PhD Cardiologist/ΗΤΑ Consultant Scientific Director, HealThink Thessaloniki,

Thank you!